About Technology Issues FAQ

Links

Official Page

First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis

First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.